COWP yields 2000000.00% · JNJ yields 2.13%● Live data
📍 COWP pulled ahead of the other in Year 1
Combined, COWP + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of COWP + JNJ for your $10,000?
Canal Capital Corporation engages in real estate and stockyard operations in the United States. The company is involved in the development, management, and sale of its real estate properties. Its real estate properties comprise exchange buildings; land and structures leased to meat packing facilities, railcar repair shops, lumber yards, and various other commercial and retail businesses; and vacant land for development or resale. The company has real estate properties in Sioux City, Iowa; South St Paul, Minnesota; St Joseph, Missouri; and Omaha, Nebraska. As of October 31, 2011, it owned approximately 2 acres of undeveloped land in Sioux City, Iowa. The company also operates a central public stockyard located in St. Joseph, Missouri. Its stockyard provides various services and facilities required to operate an independent market for the sale of livestock, including veterinary facilities, auction arenas, auctioneers, weigh masters and scales, feed and bedding facilities, and security personnel, as well as offers other services, such as pure bred and other specialty sales for producer organizations. In addition, the company sells its antiquities through independent art dealers and at public art auctions. Canal Capital Corporation was founded in 1964 and is headquartered in Port Jefferson Station, New York.
Full COWP Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.